Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › TECH Mergers & Acquisitions · Jun 25, 2026
Bio-Techne Corporation entered into a merger agreement with Merck KGaA, Darmstadt, Germany, to be acquired for $73.00… TECH BIO-TECHNE Corp
Bio-Techne Corporation entered into a merger agreement with Merck KGaA, Darmstadt, Germany, to be acquired for $73.00 per share in cash. The transaction is subject to shareholder approval and customary closing conditions. Bio-Techne Corporation is a life sciences company that provides tools and reagents for research and clinical diagnostics.
More from BIO-TECHNE Corp Bio-Techne declares $0.08 quarterly dividend payable Nov 23, contingent on Merck KGaA deal Nov 3, 2026 Bio-Techne shareholders approved the Merger Agreement with Merck KGaA, Darmstadt, Germany at a special meeting held on… Sep 23, 2026 Bio-Techne filed a supplemental disclosure regarding its proposed merger with Merck KGaA to address litigation… Sep 14, 2026 Bio-Techne Corporation reported fourth quarter fiscal 2026 results ending June 30, 2026 Aug 12, 2026 Bio-Techne Corporation and Merck KGaA, Darmstadt, Germany, have executed an Agreement and Plan of Merger, announcing a… Jun 25, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
